# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
JP Morgan analyst Jeffrey Zekauskas maintains Cabot (NYSE:CBT) with a Neutral and raises the price target from $95 to $105.
UBS analyst Joshua Spector maintains Cabot (NYSE:CBT) with a Neutral and lowers the price target from $103 to $98.
OutlookCommenting on the outlook for the Company, Keohane said, "Given the strong year-to-date results and our expectations...
Cabot (NYSE:CBT) reported quarterly earnings of $1.92 per share which beat the analyst consensus estimate of $1.72 by 11.63 per...
UBS analyst Joshua Spector maintains Cabot (NYSE:CBT) with a Neutral and raises the price target from $100 to $103.
Mizuho analyst John Roberts maintains Cabot (NYSE:CBT) with a Buy and raises the price target from $104 to $109.